Phase
Condition
Lymphoproliferative Disorders
Leukemia
Platelet Disorders
Treatment
No intervention
Clinical Study ID
Ages 3-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients must be between 3 years and 18 years of age at time of assent/consent.
Patients must have newly diagnosed B- or T-cell ALL, or mixed phenotype acuteleukemia confirmed by pathology report.
Patients must be receiving treatment at one of the participating centers.
Exclusion
Exclusion Criteria:
- Patients receiving hematopoietic cell transplant.
Study Design
Connect with a study center
Hospital de Cancer Infanto Juvenil de Barretos
Barretos,
BrazilActive - Recruiting
Instituto de Tratamento do Câncer Infantil (ITACI)
São Paulo,
BrazilActive - Recruiting
Unidad Nacional De Oncologia Pediatrica
Guatemala City,
GuatemalaActive - Recruiting
Hospital Escuela
Tegucigalpa,
HondurasActive - Recruiting
Post-Graduate Institute of Medical Education and Research (PGIMER)
Chandigarh,
IndiaSite Not Available
Muhumbili Hospital
Dar es Salaam,
TanzaniaActive - Recruiting
Columbia University Irving Medical Center
New York, New York 10032
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.